Regeneron Pharmaceuticals - REGN Short Interest Ratio & Short Volume

Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 1,200,000 shares of REGN short. 1.17% of Regeneron Pharmaceuticals' shares are currently sold short. Learn More on Regeneron Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 2.0. Learn More on Regeneron Pharmaceuticals's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Parallax Volatility Advisers L.P., Point72 Middle East FZE, Jane Street Group LLC, Squarepoint Ops LLC, Millennium Management LLC, Maven Securities LTD, Centiva Capital LP, Point72 Hong Kong Ltd, Susquehanna International Group LLP, Verition Fund Management LLC, Twin Tree Management LP, JPMorgan Chase & Co., QVR LLC, Bank of America Corp DE, Capstone Investment Advisors LLC, Group One Trading L.P., IMC Chicago LLC, Citigroup Inc., HighTower Advisors LLC, UBS Group AG, SpiderRock Advisors LLC, Cutler Group LLC CA, Simplex Trading LLC, Concourse Financial Group Securities Inc., Steel Peak Wealth Management LLC, Covenant Asset Management LLC, and XR Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.17% of Regeneron Pharmaceuticals' floating shares are currently sold short.

Regeneron Pharmaceuticals saw a drop in short interest in February. As of February 28th, there was short interest totaling 1,200,000 shares, a drop of 10.4% from the previous total of 1,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Regeneron Pharmaceuticals currently has issued a total of 109,330,000 shares. Some of Regeneron Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regeneron Pharmaceuticals currently has a public float of 102,870,000 shares.

1.17% of Regeneron Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Regeneron Pharmaceuticals: Vertex Pharmaceuticals Incorporated (1.05%), Alnylam Pharmaceuticals, Inc. (4.34%), GSK plc (0.14%), Zoetis Inc. (0.92%), Takeda Pharmaceutical Company Limited (0.16%), Sanofi (0.11%), Horizon Therapeutics Public Limited (1.43%), Genmab A/S (0.44%), Bristol-Myers Squibb (0.81%), and BeiGene, Ltd. (1.94%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading up $50.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is February, 28 2023.